4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-26-103536
Chief Scientific Officer acquired 417,416 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Grant or award | +208,125 | 1,341,263 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Grant or award | +209,291 | 1,550,554 | D | ||
| Derivatives | |||||||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −104,000 | 0 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −100,000 | 0 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −69,999 | 0 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −47,000 | 0 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −100,000 | 0 | D | ||
| Kidron Miriam Chief Scientific Officer | 2026-09-24 | Returned to the company · Stock option (right to buy) | −72,000 | 0 | D | ||
Loading xslF345X06/ownership.xml…